INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect

Author： Chiappori Alberto A   Soliman Hatem   Janssen William E   Antonia Scott J   Gabrilovich Dmitry I  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.10, Iss.6, 2010-06, pp. : 983-991

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparative Gene Expression Profiling in Response to p53 in a Human Lung Cancer Cell Line

By Song S.   MacLachlan T.K.   Meng R.D.   El-deiry W.S.  

Biochemical and Biophysical Research Communications, Vol. 264, Iss. 3, 1999-11 ,pp. : 891-895

Elsevier

Access to resources Recommend Favorite

INGN 201 (Advexin®): adenoviral p53 gene therapy for cancer

By Gabrilovich Dmitry I  

Expert Opinion on Biological Therapy, Vol. 6, Iss. 8, 2006-08 ,pp. : 823-832

Informa Healthcare

Access to resources Recommend Favorite

p73 competes with p53 and attenuates its response in a human ovarian cancer cell line

By Vikhanskaya F.   D’Incalci M.   Broggini M.  

Nucleic Acids Research, Vol. 28, Iss. 2, 2000-01 ,pp. : 513-519

Oxford University Press

Access to resources Recommend Favorite

p53 mutations, benzo[a]pyrene and lung cancer

By Krawczak Michael   Cooper David N.  

Mutagenesis, Vol. 13, Iss. 4, 1998-07 ,pp. : 319-320

Oxford University Press

Access to resources Recommend Favorite

A Small Synthetic Peptide, which Inhibits the p53-hdm2 Interaction, Stimulates the p53 Pathway in Tumour Cell Lines

By Chène P.   Fuchs J.   Bohn J.   García-Echeverría C.   Furet P.   Fabbro D.  

Journal of Molecular Biology, Vol. 299, Iss. 1, 2000-05 ,pp. : 245-253

Academic Press

Access to resources Recommend Favorite